patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: PSTI files S-3 with SEC.

S-3 filed September 26th. To allow up to $150,000,000 worth of stock, warrants or preferred stock to be issues in the future.

Share
New Message
Please login to post a reply